Immunohistochemical Study Using Monoclonal VE1 Antibody Can Substitute the Molecular Tests for Apprehension of BRAF V600E Mutation in Patients with Non-small-Cell Lung Carcinoma

<div>Immunohistochemical pathological examination of NSCLC using VE1 antibody. (a) Poorly differentiated adenocarcinoma with strong cytoplasmic staining (score+3) ×200. (b) Poorly differentiated adenocarcinoma with moderate cytoplasmic staining (score+2) ×200. (c) Moderately differentiated adenocarcinoma with weak cytoplasmic staining (score+1) ×200. (d). Positive control papillary carcinoma of the thyroid with strong cytoplasmic staining ×200.</div>

Analytical Cellular Pathology

fig1

Figure 1

Figure 1: Immunohistochemical Study Using Monoclonal VE1 Antibody Can Substitute the Molecular Tests for Apprehension of BRAF V600E Mutation in Patients with Non-small-Cell Lung Carcinoma 

Figure 1 | Immunohistochemical Study Using Monoclonal VE1 Antibody Can Substitute the Molecular Tests for Apprehension of BRAF V600E Mutation in Patients with Non-small-Cell Lung Carcinoma 